Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

CIMB: DBS Group – Add Target Price $40.20

Posted on August 10, 2022August 10, 2022 By alanyeo No Comments on CIMB: DBS Group – Add Target Price $40.20

2Q22 in line; more NIM expansion in 2H22F

  • 2Q22 net profit of S$1.82bn was broadly in line with our/consensus S$1.73bn/S$1.87bn estimates.
  • PPOP of S$2.13bn was almost exactly as we had forecast but net profit was a slight beat on lower-than-expected impairments (4bp vs. our 14bp).
  • NIM expanded 12bp qoq to 1.58%; we believe there is more upside in 2H22F as July exit NIM was above 1.8%. CTI was guided at 40%, ahead of peers.
4bp credit costs in 2Q22

? We consider 2Q22 net profit of S$1.82bn as broadly in line with our/consensus S$1.73bn/S$1.87bn estimates.

? The key variance to this set of results is credit cost. DBS recorded total impairments of S$46m or c.4bp credit costs (according to our calculations) vs. our expected 14bp. SPs for loans alone were 6bp; these were offset by a 2bp writeback in GPs (1Q22: S$55m or 5bp, FY21: S$53m or 1bp).

? NII rose c.12% qoq as NIMs rose c.12bp qoq to 1.58%. Average asset yields rose 11bp to 1.89% in 1H22 while funding costs increased 5bp to 0.38%.

? Loans inched up c.2% qoq, driven by trade and non-trade corporate loans in HK and SG. Housing loans and wealth management loans were stable qoq .

? Fee income was 14% weaker qoq (-12% yoy) as lower wealth management (-17% qoq, -21% yoy) and softer loan-related fees (-21% qoq, +3% yoy) offset stronger credit card fees (+9% qoq, +23% yoy). Treasury income also moderated due to less favourable market conditions.

? PPOP held steady qoq (+4% yoy) at S$2.13bn on the back of stable opex.

? DBS declared S$0.36 DPS for 2Q22 (1Q22: S$0.33).

DBS’s outlook guidance

? Business momentum of various revenue engines was mixed. Guidance for full-year loan growth of mid-single-digit percentage was unchanged. Fee income likely bottomed in 2Q22.

? The bank sees earnings upside from accelerated interest rate increases flowing through. NII sensitivity remains at S$18m-20m per basis point of US$ rates. July NIM was above 1.8%.

? CTI to improve towards 40%. Asset quality remains resilient.

Other key highlights

? Loan growth: 2% qoq in 2Q22 (1Q22: +1.5% qoq, FY21: +9.8%).
? NPL: 1.3% in 2Q22 (1Q21: 1.5%). CTI: 44% in 2Q22 (1Q22: 44%, FY21: 45%).
? CET1: 14.2% in 2Q22 (1Q21: 14.4%). ROE: 13.4% in 2Q22 (1Q22: 11%, FY21: 12.5%).

Reiterate Add and GGM-based TP of S$40.20

? We see neutral share price movement on the back of this set of results. Altho ugh results were in line, NIM expansion in the quarter was softer vs. its peers.

DBSClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:DBS Group Holdings

Post navigation

Previous Post: UOBKH: Oversea-Chinese Banking Corp – Buy Target Price $16.18
Next Post: CIMB: Manulife US REIT – Add Target Price US$0.78 (Previous US$0.86)

Related Posts

DBS: What lies ahead as earnings peak? – Singapore Banks Research - Equities
UOBKH: Banking – Singapore (Overweight) Research - Equities
CIMB: Technical Analysis – S&P500, NASDAQ, STI, OCBC, DBS, UOB Research - Equities
UOBKH: Banking – Singapore (Overweight) Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: Singapore Banks Research - Equities
PhillipCapital: Singapore Banking Monthly Research - Equities
Maybank: DBS Group – Buy Target Price $42.18 Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: DBS Group – Buy Target Price $42.18 Research - Equities
UOBKH: Singapore Monthly Review and Outlook Research - Equities
UOBKH: STRATEGY – SINGAPORE Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme